🟢 Regeneron Pharmaceuticals is trading 4.8% up in pre-market with no clear company-specific catalyst

Regeneron Pharmaceuticals is trading 4.8% up at $831.71, with no clear company-specific catalyst identified.

• It closed at $793.26 on September 10, 2026.
• The gain exceeds roughly 0.6% pre-market advances in the S&P 500, Nasdaq, and Dow.
• Recent coverage includes a Wells Fargo healthcare conference presentation and investor lawsuit deadline notices; neither clearly explains the sharp same-day gain.